← SynDRA
EFAROXAN
SynDRA canonical compound SYN0002776 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ADORA2A |
|---|
| Mechanism of action | adrenergic receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- adrenergic receptor antagonist
Drug classes
- Adrenergic alpha-Antagonists
Cross-references
Synonyms
- Efaroxano
- NSC-759562
- Efaroxanum
- G00490L21H
- NSC 759562
- DTXCID6025149
- 2-((2-ethyl-2,3-dihydrobenzofuran-2-yl))-2-imidazoline
- RefChem:136323
- 2-(2-ethyl-3H-1-benzofuran-2-yl)-4,5-dihydro-1H-imidazole
- Efaroxan (hydrochloride)
- NCGC00015410-04
- RX 821037
- Efaroxanum [INN-Latin]
- Efaroxano [INN-Spanish]
- CAS-89197-32-0
- Efaroxan [INN:BAN]
- UNII-G00490L21H
- Spectrum_001997
- EFAROXAN [INN]
- Spectrum3_001863
- Lopac0_000521
- BSPBio_003306
- KBioSS_002570
- SCHEMBL127096
- SCHEMBL29368577
- CHEBI:93806
- KBio2_002561
- KBio2_005129
- KBio2_007697
- KBio3_002808
- RATZLMXRALDSJW-UHFFFAOYSA-N
- (+-)-2-(2-Ethyl-2,3-dihydro-2-benzofuranyl)-2-imidazoline
- HMS2089D15
- Tox21 110139
- Tox21_110139
- BDBM50179393
- Tox21_110139_1
- CCG-204611
Look up EFAROXAN in the interactive SynDRA portal →